Biblio

Export 238 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
V. Berisha, Wang, S., LaCross, A., and Liss, J., “Tracking Discourse Complexity Preceding Alzheimer's Disease Diagnosis: A Case Study Comparing the Press Conferences of Presidents Ronald Reagan and George Herbert Walker Bush.”, J Alzheimers Dis, 2015.
A. Katrine Bergland, Dalen, I., Larsen, A. Inge, Aarsland, D., and Soennesyn, H., “Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.”, J Alzheimers Dis, vol. 56, no. 2, pp. 575-584, 2017.
A. Katrine Bergland, Proitsi, P., Kirsebom, B. - E., Soennesyn, H., Hye, A., Larsen, A. Inge, Xu, J., Legido-Quigley, C., Rajendran, L., Fladby, T., and Aarsland, D., “Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1117-1127, 2020.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., “Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.”, J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
M. F. Bergeron, Landset, S., Zhou, X., Ding, T., Khoshgoftaar, T. M., Zhao, F., Du, B., Chen, X., Wang, X., Zhong, L., Liu, X., and J Ashford, W., “Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1545-1558, 2020.
D. Bergeron, Vermette, A., De La Sablonnière, J., Cayer, A. - M., Laforce, R., and Bouchard, R. W., “Finger-to-Nose Test Findings in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1335-1337, 2017.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., “APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
M. Berger, Nadler, J. W., Friedman, A., McDonagh, D. L., Bennett, E. R., Cooter, M., Qi, W., Laskowitz, D. T., Ponnusamy, V., Newman, M. F., Shaw, L. M., Warner, D. S., Mathew, J. P., and James, M. L., “The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1299-310, 2016.
G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, “Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.”, J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
J. - L. Berg, Durant, J., Léger, G. C., Cummings, J. L., Nasreddine, Z., and Miller, J. B., “Comparing the Electronic and Standard Versions of the Montreal Cognitive Assessment in an Outpatient Memory Disorders Clinic: A Validation Study.”, J Alzheimers Dis, vol. 62, no. 1, pp. 93-97, 2018.
C. Berezuk, Zakzanis, K. K., Ramirez, J., Ruocco, A. C., Edwards, J. D., Callahan, B. L., and Black, S. E., “Functional Reserve: Experience Participating in Instrumental Activities of Daily Living is Associated with Gender and Functional Independence in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 2, pp. 425-434, 2017.
G. Bera, Migliaccio, R., Michelin, T., Lamari, F., Ferrieux, S., Nogues, M., Bertin, H., Habert, M. Odile, Dubois, B., Teichmann, M., and Kas, A., “Parietal Involvement in the Semantic Variant of Primary Progressive Aphasia with Alzheimer's Disease Cerebrospinal Fluid Profile.”, J Alzheimers Dis, vol. 66, no. 1, pp. 271-280, 2018.
A. Benvenutto, Giusiano, B., Koric, L., Gueriot, C., Didic, M., Felician, O., Guye, M., Guedj, E., and Ceccaldi, M., “Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1147-1157, 2018.
L. Benussi, Ghidoni, R., Dal Piaz, F., Binetti, G., Di Iorio, G., and Abrescia, P., “The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 825-833, 2017.
D. Bensamoun, Guignard, R., Furst, A. J., Derreumaux, A., Manera, V., Darcourt, J., Benoit, M., Robert, P. H., and David, R., “Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.”, J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.
M. Reda Bensaïdane, Beauregard, J. - M., Poulin, S., Buteau, F. - A., Guimond, J., Bergeron, D., Verret, L., Fortin, M. - P., Houde, M., Bouchard, R. W., Soucy, J. - P., and Laforce, R., “Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
K. Bennys, Gabelle, A., Berr, C., De Verbizier, D., Andrieu, S., Vellas, B., and Touchon, J., “Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 87-97, 2017.
D. A. Bennett, Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., and Schneider, J. A., “Religious Orders Study and Rush Memory and Aging Project.”, J Alzheimers Dis, vol. 64, no. s1, pp. S161-S189, 2018.
J. Bennett, Burns, J., Welch, P., and Bothwell, R., “Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.
M. R. BenKhedher, Haddad, M., Fülöp, T., Laurin, D., and Ramassamy, C., “Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 2, pp. 813-825, 2023.
J. Benito-León, Contador, I., Mitchell, A. J., Domingo-Santos, Á., and Bermejo-Pareja, F., “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
X. Bengoetxea, de Cerain, A. López, Azqueta, A., and Ramirez, M. J., “Purported Interactions of Amyloid-β and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1085-1094, 2016.
R. Benca, W Herring, J., Khandker, R., and Qureshi, Z. P., “Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.”, J Alzheimers Dis, vol. 86, no. 1, pp. 83-109, 2022.
A. Benaque, Gurruchaga, M. Jone, Abdelnour, C., Hernandez, I., Cañabate, P., Alegret, M., Rodríguez, I., Rosende-Roca, M., Tartari, J. Pablo, Esteban, E., López, R., Gil, S., Vargas, L., Mauleón, A., Espinosa, A., Ortega, G., Sanabria, Á., Pérez, A., Alarcón, E., González-Pérez, A., Marquié, M., Valero, S., Tárraga, L., Ruiz, A., and Boada, M., “Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain.”, J Alzheimers Dis, vol. 76, no. 1, pp. 33-40, 2020.
G. Ben-Sadoun, Sacco, G., Manera, V., Bourgeois, J., König, A., Foulon, P., Fosty, B., Bremond, F., d'Arripe-Longueville, F., and Robert, P., “Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1299-314, 2016.

Pages